ENALAPRILAT ANHYDROUS

SynDRA canonical compound SYN0000915 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	ACE
Mechanism of action	Angiotensin converting enzyme inhibitor
Indication	hypertension
Disease area	cardiology

All known targets

enalaprilat
enalapril acid
enalaprilate
enalaprilic acid
enalaprilat hydrate
enalaprilat dihydrate
Enalaprilat
EAL
Enalaprilate
Enalaprilatum
ENALAPRILAT INHIBITOR
Enalapril acid
Enalapril diacid
Enalaprilic acid
Enalprilat hydrate
Enalprilate hydrate
Enalaprilat (USP)
MK-422
Vasotec I.V.
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline
N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline-water (1/2)
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid
(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid dihydrate
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE
1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline dihydrate
Enalapril diacid dihydrate
Vasotec i.v.
GV0O7ES0R3
Q508Q118JM
enalapril maleate impurity c (ep impurity)
L-PROLINE, 1-(N-(1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-, (S)-
enalaprilat (usp monograph)
1-(N-((S)-1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-L-PROLINE
enalaprilat dihydrate (ep monograph)
ENALAPRILAT
ENALAPRILAT DIHYDRATE
enalaprilat (usp-rs)
NSC 760053
Enalapril diacid dihydrate anhydrous